The tweet was deleted by the author.
But we saved everything 🙂.
CVRx has appointed Michael Dale as a new member of its Board of Directors.
Dale brings decades of leadership experience in the medical device sector and is known for a strong track record in driving growth and innovation. The company expressed confidence that his insights and strategic guidance will benefit its board and overall strategy moving forward.
CVRx has recently marked the completion of 50 Barostim implants at Wellstar Kennestone, advancing its presence in heart failure treatment options, according to a company announcement. The company is also focusing on clinical integration with plans to host a Barostim symposium at AAHFN2026 for advanced practice providers, as stated in an earlier update. These initiatives reflect ongoing efforts to expand Barostim adoption.